High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction.
about
Lipoprotein-associated phospholipase-A2 activity and its diagnostic potential in patients with acute coronary syndrome and acute ischemic stroke.C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke studyInflammatory mechanisms of stroke.Inflammatory biomarkers of vascular risk as correlates of leukoariosis.Atherosclerotic plaque biomarkers: beyond the horizon of the vulnerable plaque.Periodontal microbiota and phospholipases: the Oral Infections and Vascular Disease Epidemiology Study (INVEST).Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke.Molecular mechanisms underlying application of serum procalcitonin and stool miR-637 in prognosis of acute ischemic stroke.High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study.Role of C-reactive protein in cerebrovascular disease: a critical review.Therapeutic Options to Reduce Lp-PLA2 Levels and the Potential Impact on Vascular Risk Reduction.Routine serum C-reactive protein and stroke outcome after intravenous thrombolysis.New predictors of adverse cardiovascular events following vascular surgery.Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction.
P2860
Q33764961-FB68ED87-6EAD-4D28-83A1-99F576FF165EQ33966178-40E52D43-D885-4707-99B5-F6AF0A8B5B6CQ34235537-9B9F2371-E8B0-4AF6-8B07-380EB8EC8233Q35045118-08426477-93F1-4731-A68C-934C98941069Q35092141-517B94B0-1CAB-4409-80F8-65D48AB95E81Q35748267-F5DF61EA-9D4A-43C0-96BF-1D751F02CF18Q36272238-5A51BA39-5B40-4E14-B147-E7B39C5FDE3FQ37393419-447CA3F4-F3FD-4CA2-8C40-AC091A609C97Q37393454-7E412700-C3DC-4512-8F41-D3544A074999Q37959060-8E3535E8-49CD-4CAB-96F4-79672FF66AA4Q44652488-1CA6255D-C7E6-4E9D-81BD-3E6CC1F31695Q44792514-C4B19C0F-2A7F-440A-BAB4-C8CDB5547A51Q44990745-86FB6972-4BA2-473E-8B0F-C4B3FA760375Q47103077-69FF9595-855C-4FA2-A41E-FA9D95B4373E
P2860
High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
High-sensitivity C-reactive pr ...... oke and myocardial infarction.
@en
High-sensitivity C-reactive pr ...... oke and myocardial infarction.
@nl
type
label
High-sensitivity C-reactive pr ...... oke and myocardial infarction.
@en
High-sensitivity C-reactive pr ...... oke and myocardial infarction.
@nl
prefLabel
High-sensitivity C-reactive pr ...... oke and myocardial infarction.
@en
High-sensitivity C-reactive pr ...... oke and myocardial infarction.
@nl
P2093
P2860
P1433
P1476
High-sensitivity C-reactive pr ...... oke and myocardial infarction.
@en
P2093
Mitchell S V Elkind
Myunghee C Paik
Vladimir Leon
Yeseon P Moon
P2860
P304
P356
10.1161/STROKEAHA.109.552802
P407
P577
2009-07-30T00:00:00Z